Literature DB >> 26963462

Radiation Therapy for Soft-Tissue Sarcomas: A Primer for Radiologists.

Jeremy R Wortman1, Sree Harsha Tirumani1, Jyothi P Jagannathan1, Michael H Rosenthal1, Atul B Shinagare1, Jason L Hornick1, Elizabeth H Baldini1, Nikhil H Ramaiya1.   

Abstract

Radiation therapy (RT) plays an important role in multimodality therapy for soft-tissue sarcomas (STS). RT treatment paradigms have evolved significantly in recent years, and many different complex RT modalities are commonly used in STS. These include external-beam RT, intensity-modulated RT, stereotactic body RT, and brachytherapy. Imaging is essential throughout the treatment process. Plain radiographs, computed tomography (CT), magnetic resonance imaging, ultrasonography, and positron emission tomography/CT all play potential roles in the management of STS. Before RT, high-quality imaging is needed to direct management decisions, both by global tumor staging and detailed assessment of the extent of local disease. At the time of RT, precise planning imaging is required to delineate tumor volumes, including gross tumor volume, clinical target volume, and planning target volume, which are used to direct therapy. In addition, imaging at the time of RT must outline the location of adjacent vital organs, to optimize treatment efficacy and minimize toxicity. After RT, imaging is needed to assess the patient for tumor response to therapy. In addition, imaging at regular intervals is often required to monitor for recurrence of disease and potential complications of therapy. The purpose of this review is to familiarize radiologists with the indications for RT in STS, common therapeutic modalities used, roles of imaging throughout the treatment process, and complications of therapy. (©)RSNA, 2016.

Entities:  

Mesh:

Year:  2016        PMID: 26963462     DOI: 10.1148/rg.2016150083

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  4 in total

Review 1.  [Soft tissue sarcoma: how can posttreatment alterations be distinguished from recurrences?]

Authors:  I-M Noebauer-Huhmann; T Grieser
Journal:  Radiologe       Date:  2017-11       Impact factor: 0.635

2.  Soft Tissue Sarcoma Stiffness and Perfusion Evaluation by MRE and DCE-MRI for Radiation Therapy Response Assessment: A Technical Feasibility Study.

Authors:  Kay Pepin; Roger Grimm; Soudabeh Kargar; B Matthew Howe; Karen Fritchie; Matthew Frick; Doris Wenger; Scott Okuno; Richard Ehman; Kiaran McGee; Sarah James; Nadia Laack; Michael Herman; Deanna Pafundi
Journal:  Biomed Phys Eng Express       Date:  2019-05-22

3.  Treatment Outcomes and Prognostic Factors of Adult Sinonasal Sarcomas: A Single-Institution Case Series.

Authors:  Jianming Ding; Cuihong Wang; Jun Xiang; Chunying Shen; Chaosu Hu; Tingting Xu; Xueguan Lu
Journal:  Med Sci Monit       Date:  2018-09-02

4.  The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma.

Authors:  Marta Kobus; Siyer Roohani; Felix Ehret; Anne Flörcken; Jana Käthe Striefler; Franziska Brandes; Sven Märdian; Daniel Rau; Silvan Wittenberg; Robert Öllinger; David Kaul
Journal:  Radiat Oncol       Date:  2022-08-08       Impact factor: 4.309

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.